|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1635 SEK | +0.62% |
|
-1.51% | -8.91% |
| 05-22 | XP Chemistries reports Q1 operating profit of SEK -3.07 mln | RE |
| 05-22 | XP Chemistries AB Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 51.34M 5.3M 4.65M 4.31M 3.96M 7.5M 507M 7.64M 20.13M 249M 19.91M 19.47M 861M | P/E 2024 |
-1.48x | P/E 2025 | -5.22x |
|---|---|---|---|---|---|
| Enterprise Value | 36.11M 3.73M 3.27M 3.03M 2.79M 5.27M 357M 5.38M 14.16M 175M 14M 13.7M 605M | EV / Sales 2024 |
43.7x | EV / Sales 2025 | 126x |
| Free-Float |
42.26% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.62% | ||
| 1 week | -1.51% | ||
| Current month | -3.54% | ||
| 1 month | -4.94% | ||
| 3 months | -11.62% | ||
| 6 months | -10.41% | ||
| Current year | -8.91% |
| 1 week | 0.15 | 0.17 | |
| 1 month | 0.15 | 0.18 | |
| Current year | 0.15 | 0.2 | |
| 1 year | 0.15 | 0.34 | |
| 3 years | 0.03 | 0.58 | |
| 5 years | 0.03 | 4.5 | |
| 10 years | 0.03 | 4.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Nelsson
CEO | Chief Executive Officer | 43 | 01/01/2021 |
Anders Frejdh
DFI | Director of Finance/CFO | 52 | 01/01/2021 |
Shuang Zheng Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Armando Córdova
CHM | Chairman | 56 | 01/01/2015 |
Jonas Hafrén
BRD | Director/Board Member | 57 | 01/01/2021 |
Samson Afewerki
BRD | Director/Board Member | 41 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/04/24 | Buy | Chief Executive Officer | 50,000 | 0.0340% | ||
| 15/04/24 | Buy | Chief Executive Officer | 20,000 | 0.0136% | ||
| 15/04/24 | Buy | Chief Executive Officer | 30,000 | 0.0204% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.62% | -1.51% | -51.91% | -67.94% | 5.29M | ||
| -0.56% | -1.52% | +47.86% | +171.88% | 1,060B | ||
| +0.31% | -0.60% | +64.37% | +62.31% | 619B | ||
| -0.03% | -2.65% | +29.49% | +85.64% | 438B | ||
| -1.75% | -2.91% | +28.78% | +24.35% | 333B | ||
| +0.24% | -2.61% | +29.46% | +46.50% | 282B | ||
| -1.75% | -12.77% | +20.67% | +23.05% | 267B | ||
| +0.67% | -0.76% | -26.10% | -37.25% | 218B | ||
| -0.81% | -1.63% | +21.35% | +58.33% | 196B | ||
| +1.21% | +1.38% | +17.23% | +71.29% | 161B | ||
| Average | -0.14% | -3.21% | +18.12% | +43.82% | 357.39B | |
| Weighted average by Cap. | -0.09% | -3.10% | +35.85% | +84.06% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 284K 29.33K 25.72K 23.82K 21.92K 41.46K 2.81M 42.27K 111K 1.38M 110K 108K 4.76M | 327K 33.81K 29.66K 27.47K 25.27K 47.81K 3.24M 48.74K 128K 1.59M 127K 124K 5.49M |
| Net income | -7.13M -737K -646K -599K -551K -1.04M -70.52M -1.06M -2.8M -34.63M -2.77M -2.71M -120M | -8.52M -880K -772K -715K -658K -1.24M -84.23M -1.27M -3.34M -41.36M -3.3M -3.23M -143M |
| Net Debt | -2.15M -222K -194K -180K -166K -313K -21.21M -319K -841K -10.41M -832K -814K -35.96M | -15.23M -1.57M -1.38M -1.28M -1.18M -2.22M -151M -2.27M -5.97M -73.92M -5.91M -5.78M -255M |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | SEK 0.1635 | +0.62% | 114,543 |
| 10/07/26 | SEK 0.1625 | -0.61% | 208,836 |
| 09/07/26 | SEK 0.1635 | -1.80% | 526,764 |
| 08/07/26 | SEK 0.1665 | +0.30% | 24,144 |
| 07/07/26 | SEK 0.1660 | +1.22% | 161,982 |
- Stock Market
- Stocks
- XPC Stock
Select your edition
All financial news and data tailored to specific country editions
















